Annette Frushour
Family · Crest Hill, ILNPI 1558792036
Payments from drug & device makers
Across 206 payments — averaging $19.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$554
- AstraZeneca$539
- AbbVie$440
- GSK$348
- Lilly USA, LLC$323
- Boehringer Ingelheim$256
- plus $2K from 19 others
What the payments were for
- Food & beverage$3,93398%
- Education$852%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 32 | $554 |
| AstraZeneca | 29 | $539 |
| AbbVie | 22 | $440 |
| GSK | 19 | $348 |
| Lilly USA, LLC | 18 | $323 |
| Boehringer Ingelheim | 12 | $256 |
| Pfizer | 10 | $185 |
| Exact Sciences | 9 | $167 |
| Merck | 7 | $166 |
| Johnson & Johnson | 6 | $155 |
| Astellas Pharma US Inc | 4 | $150 |
| Dexcom, Inc. | 4 | $133 |
| E.r. Squibb & Sons, L.L.C. | 6 | $97 |
| Abbott | 4 | $90 |
| Axsome Therapeutics, Inc. | 3 | $67 |
| Bayer | 4 | $64 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $60 |
| Phathom Pharmaceuticals, Inc. | 3 | $55 |
| Idorsia Pharmaceuticals US Inc | 2 | $36 |
| Phadia US Inc. | 2 | $36 |
| Amgen | 2 | $33 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| Amarin Pharma, Inc. | 1 | $15 |
| Boston Scientific | 1 | $13 |
| Vistapharm, Inc. | 1 | $11 |
How this compares
$4,018 in reported general payments places this provider in the 90th percentile of 4,941 family providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 34 | $31,817 |
| TrulicityDulaglutide | 21 | $23,762 |
| OzempicSemaglutide | 26 | $22,923 |
| JardianceEmpagliflozin | 13 | $19,830 |
| JanuviaSitagliptin Phosphate | 12 | $17,945 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 26 | $4,630 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 46 | $1,605 |
| Omeprazole | 58 | $1,351 |
| Levothyroxine Sodium | 81 | $854 |
| Ventolin HfaAlbuterol Sulfate | 11 | $806 |
| Atorvastatin Calcium | 114 | $753 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 73 | $744 |
| Lisinopril | 61 | $667 |
| Metformin Hcl | 90 | $591 |
| Amlodipine Besylate | 89 | $539 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $348 | $31,81734 claims |
| Lilly USA, LLCTrulicity | $323 | $23,76221 claims |
| Novo NordiskOzempic | $554 | $22,92326 claims |
| Boehringer IngelheimJardiance | $256 | $19,83013 claims |
| MerckJanuvia | $166 | $17,94512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,941 family providers in Illinois.
Other family in Crest Hill
- Ruth CarricoChicago$582K
- Aleksandra BielawiecBarrington$373K
- Erin SieberNaperville$334K
- Jamie BroganChicago$282K
- Ashley NoethGlen Carbon$271K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Brooke KennardBloomington$208K
- Amy BrownellElk Grove Village$202K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.